chronic
liver
diseas
multipl
etiolog
includ
viral
infect
metabol
disord
regardless
initi
caus
progress
liver
fibrosi
cirrhosi
requir
inflammatori
compon
fibrogen
process
continu
wound
heal
respons
mediat
hepat
stellat
cell
hsc
activ
interact
innat
adapt
immun
cell
excess
wound
heal
due
uncontrol
hepatocyt
death
upon
persist
hepatocellular
stress
result
patholog
fibrogenesi
evid
clinic
anim
studi
suggest
hepat
macrophag
play
import
role
stage
liver
diseas
import
properti
macrophag
liver
patholog
abil
induc
hepatocellular
apoptosi
liver
injuri
resid
macrophag
known
kupffer
cell
kc
critic
initi
stress
respons
kc
respond
rapidli
produc
cytokin
includ
inflammatori
cytokin
releas
result
leukocyt
recruit
leukocytederiv
death
receptor
ligand
releas
propag
hepatocyt
apoptosi
contribut
hepatopatholog
death
effector
induc
apoptosi
engag
tnf
receptor
superfamili
member
hepatocyt
result
hepatocyt
death
central
liver
pathophysiolog
common
diseas
model
process
macrophag
known
particip
regul
hepatocyt
death
contribut
hepat
fibrosi
aris
inflamm
liver
initi
resid
macrophag
activ
massiv
leukocyt
accumul
hepat
macrophag
hold
central
posit
maintain
homeostasi
liver
pathogenesi
acut
chronic
liver
injuri
link
fibrogenesi
interferon
regulatori
factor
recent
emerg
import
proinflammatori
transcript
factor
involv
macrophag
activ
acut
chronic
inflamm
reveal
significantli
induc
liver
macrophag
human
subject
develop
liver
fibrosi
nonalcohol
fatti
liver
diseas
hepat
c
viru
infect
furthermor
express
posit
correl
clinic
marker
liver
damag
plasma
transaminas
bilirubin
level
interestingli
mice
lack
myeloid
cell
mko
protect
hepat
fibrosi
induc
metabol
toxic
stress
transcript
reprogram
macrophag
lack
character
immunosuppress
antiapoptot
properti
consequ
mko
mice
respond
hepatocellular
stress
promot
hepatocyt
surviv
lead
complet
protect
hepat
fibrogenesi
find
reveal
regulatori
network
govern
mediat
hepatocyt
death
liver
fibrosi
mice
human
therefor
modul
function
may
attract
approach
experiment
therapeut
fibroinflammatori
liver
diseas
pathogenesi
nonalcohol
steatohepat
nash
viral
hepat
c
hcv
interestingli
target
delet
resid
infiltr
macrophag
fibrogenesi
amelior
end
phenotyp
macrophag
deplet
resolut
exacerb
fibrosi
oppos
action
part
explain
variat
infiltr
macrophag
subset
destin
play
differ
role
liver
fibrosi
macrophag
character
high
plastic
respons
microenviron
tradit
macrophag
categor
termin
differenti
stage
proinflammatori
wound
heal
immunosuppress
reg
macrophag
differenti
depend
regulatori
cascad
control
interferon
regulatori
factor
irf
irf
famili
transcript
factor
involv
immunoregul
immun
cell
differenti
tlr
signal
recent
document
fifth
member
irf
express
myeloid
cell
respons
macrophag
polar
macrophag
activ
also
elicit
th
cell
type
respons
acut
chronic
inflamm
recent
demonstr
metabol
activ
obes
involv
adipos
tissu
expans
knockout
prevent
adipos
tissu
expans
altern
polar
macrophag
cell
respons
current
studi
reveal
increas
express
human
liver
fibrosi
due
hcv
infect
nonalcohol
fatti
liver
diseas
nafld
addit
express
correl
marker
liver
damag
bilirubin
transaminas
suggest
key
function
liver
patholog
causal
associ
confirm
mice
myeloid
defici
mko
mko
mice
resist
liver
fibrosi
upon
carbon
tetrachlorideinduc
ccl
induc
experiment
fibrosi
nafldlik
patholog
induc
methionin
cholinedefici
mcd
feed
due
cholestat
injuri
bile
duct
ligat
bdl
underli
protect
phenotyp
immunosuppress
polar
liver
macrophag
consequ
hepatocyt
desensit
death
receptor
stimul
turn
amelior
initi
respons
hepatocellular
stress
address
associ
develop
human
liver
fibrosi
steatohepat
quantifi
mrna
level
liver
biopsi
subject
normal
liver
fatti
liver
nash
hcv
significantli
higher
express
observ
nash
hcv
group
compar
control
figur
cohort
express
strongli
induc
fibrosi
stage
fatti
liver
steatosi
figur
supplement
figur
supplement
materi
avail
onlin
articl
confirm
gene
express
result
cell
specif
express
analyz
ihc
local
panmacrophag
marker
liver
section
subject
immunostain
restrict
liver
sinusoid
fibrou
septa
coloc
immunostain
note
observ
local
endotheli
cell
hsc
supplement
figur
furthermor
stain
increas
extent
liver
damag
fibrosi
nash
hcv
figur
next
investig
correl
mrna
level
main
liver
function
paramet
express
correl
posit
plasma
transaminas
bilirubin
level
neg
prothrombin
time
indic
increas
express
marker
reflect
liver
damag
figur
observ
human
strongli
suggest
involv
pathogenesi
steatohepat
liver
fibrosi
order
investig
role
liver
fibrosi
use
murin
model
nash
hepat
fibrosi
chronic
hepatocellular
stress
induc
repeat
administr
ccl
induct
experiment
fibrosi
mcd
feed
bdl
induct
nashlik
patholog
cholestat
liver
injuri
respect
follow
treatment
fibrogenesi
assess
red
picrosiriu
rp
stain
structur
damag
assess
h
e
stain
macrophag
accumul
quantifi
stain
confirm
mcd
feed
lead
lipid
accumul
mild
fibrosi
macrophag
accumul
bdl
lead
intermedi
fibrosi
macrophag
accumul
parenchym
necrosi
wherea
ccl
treatment
lead
pronounc
fibrosi
massiv
macrophag
accumul
figur
b
mice
treat
mcd
bdl
ccl
express
significantli
increas
rel
untreat
mice
measur
ihc
analysi
increas
express
concord
sever
liver
damag
macrophag
accumul
figur
previous
report
express
modul
liver
liver
macrophag
mice
fed
highfat
diet
supplement
figur
b
interestingli
stain
local
region
stain
indic
local
express
murin
liver
macrophag
local
sinusoid
region
inflammatori
infiltr
fibrou
septa
follow
mcd
bdl
ccl
treatment
figur
confirm
induct
liver
macrophag
mrna
level
quantifi
qrtpcr
liver
hepat
macrophag
cell
anim
express
induc
liver
liver
macrophag
follow
mcd
bdl
ccl
treatment
figur
increas
express
specif
liver
macrophag
modul
seen
hepatocyt
supplement
figur
b
furthermor
express
macrophag
correl
sever
marker
diseas
progress
name
macrophag
accumul
express
plasma
transaminas
fibrosi
rp
stain
express
figur
myeloid
defici
prevent
hepat
fibrosi
vivo
address
causal
associ
among
liver
inflamm
fibrosi
gener
mko
mice
previous
describ
delet
express
hepat
macrophag
mko
mice
confirm
ihc
immunoblot
qrtpcr
figur
supplement
figur
subject
mko
mice
wildtyp
litterm
mwt
mcd
feed
week
bdl
day
repeat
ccl
administr
week
result
hepat
phenotyp
analyz
model
liver
mko
mice
underw
significantli
less
structur
chang
h
e
stain
mwt
mice
figur
inde
quantif
fibrosi
rp
stain
reveal
decreas
accumul
collagen
mko
mice
accompani
decreas
mrna
express
compar
mwt
upon
mcd
bdl
ccl
treatment
figur
hsc
activ
major
process
lead
collagen
deposit
also
decreas
mko
mice
model
evalu
quantif
express
ihc
qrtpcr
analys
figur
protect
liver
phenotyp
mko
mice
reflect
decreas
plasma
transaminas
level
mko
mice
rel
mwt
mice
model
figur
result
indic
lower
degre
liver
damag
remodel
mko
mice
upon
mcd
bdl
ccl
treatment
sinc
express
restrict
hepat
cell
figur
supplement
figur
next
object
defin
phenotyp
hepat
macrophag
popul
mwt
mko
mice
follow
mcd
bdl
ccl
treatment
interestingli
macrophag
number
strongli
reduc
liver
mko
mice
compar
mwt
mice
treatment
quantifi
immunostain
gene
express
total
liver
figur
furthermor
fac
analys
liver
mononuclear
cell
lmnc
reveal
decreas
accumul
macrophag
liver
mko
mice
figur
next
identifi
polar
hepat
macrophag
popul
gate
onto
proinflammatori
macrophag
marker
antiinflammatori
reg
macrophag
marker
observ
phenotyp
switch
macrophag
popul
decreas
macrophag
increas
macrophag
mko
rel
mwt
mice
treatment
figur
find
suggest
downregul
pathway
subsequ
antiinflammatori
polar
mko
hepat
macrophag
implic
hepatoprotect
phenotyp
upon
mcd
bdl
ccl
treatment
identifi
transcript
pathway
differenti
express
liver
macrophag
carri
transcriptom
analys
rna
sequenc
hepat
cell
mwt
mko
mice
treat
ccl
transcriptom
analys
reveal
differenti
express
transcript
mko
mwt
mice
ontolog
cluster
pathway
analys
reveal
enrich
multipl
term
among
downregul
transcript
regul
apoptosi
cytokin
signal
tlr
signal
cell
activ
tabl
expect
pathway
downregul
hepat
cell
mko
mice
figur
consequ
proinflammatori
gene
mhc
ii
tnf
downregul
antiinflammatori
immunosuppress
gene
upregul
corrobor
phenotyp
switch
seen
flow
cytometr
analys
differenti
expr
figur
express
human
hepat
macrophag
induc
human
nash
hepat
fibrosi
interferon
regulatori
factor
mrna
express
liver
biopsi
control
patient
normal
liver
n
patient
fatti
liver
n
nonalcohol
steatohepat
nash
n
hepat
c
viru
infect
hcv
n
b
mrna
express
cohort
patient
n
stratifi
fibrosi
stage
c
repres
imag
pink
stain
brown
stain
immunostain
liver
section
select
patient
coloc
stain
shown
red
arrow
correl
analys
mrna
express
plasma
aspart
alanin
transaminas
ast
alt
respect
level
bilirubin
level
prothrombin
time
cohort
patient
n
scale
bar
differ
patient
group
determin
anova
correl
analys
assess
spearman
test
valu
report
mean
sem
p
correl
determin
fibrosi
liver
collagen
type
alpha
mrna
express
plasma
aspart
transferas
ast
alanin
transferas
alt
liver
mrna
express
normal
chow
mcd
bdl
ccl
treat
mice
n
per
group
scale
bar
correl
analys
assess
spearman
test
differ
dietstreat
determin
anova
valu
report
mean
sem
p
p
p
sion
inflammatori
gene
confirm
qrtpcr
analysi
figur
also
observ
signific
reduct
mrna
express
level
mko
macrophag
supplement
figur
accord
enrich
go
term
lymphocyt
activ
observ
decreas
express
fibrokin
among
liver
cell
figur
enrich
term
among
upregul
transcript
repres
normal
metabol
function
liver
cell
mko
rel
mwt
mice
supplement
tabl
n
per
group
differ
genotyp
determin
unpair
twotail
test
valu
report
mean
sem
p
p
myeloid
defici
prevent
faslink
hepatocyt
apoptosi
apoptosi
term
significantli
enrich
among
downregul
transcript
hepat
cell
mko
mice
thu
quantifi
apoptot
necrot
bodi
tunel
assay
liver
mwt
mko
mice
upon
ccl
treatment
tunel
stain
histolog
local
hepatocyt
observ
liver
mwt
mko
mice
confirm
downregul
cell
death
figur
among
apoptot
pathway
faslink
apoptosi
highlight
pathway
analys
downregul
hepat
macrophag
mko
mice
figur
confirm
combin
ihc
qrtpcr
fasl
express
reduc
liver
section
liver
macrophag
mko
compar
mwt
mice
figur
also
reveal
flow
cytometri
hepat
macrophag
mko
mice
defect
fasl
tnf
releas
compar
mwt
mice
figur
interestingli
ihc
analysi
reveal
similar
local
fasland
tunelposit
stain
confirm
hepatocyt
target
fasinduc
apoptosi
mwt
mice
observ
corrobor
decreas
express
fa
fasl
receptor
increas
express
antiapoptot
gene
bclx
l
hepatocyt
mko
mice
compar
mwt
litterm
control
figur
apoptosi
earli
event
initi
scar
tissu
deposit
fibrogenesi
thu
character
acut
respons
ccl
administr
mwt
mko
mice
follow
acut
ccl
toxic
observ
disrupt
liver
structur
mwt
mice
appear
necroticapoptot
region
massiv
hepatocyt
balloon
visual
h
e
stain
structur
damag
minim
liver
mko
mice
corrobor
decreas
plasma
transaminas
level
strongli
induc
mwt
mice
figur
importantli
express
also
strongli
induc
mwt
acut
ccl
toxic
quantifi
ihc
qrtpcr
analysi
hepat
cell
figur
along
induct
mwt
mice
notic
increas
accumul
macrophag
mwt
mko
liver
figur
addit
mko
mice
accumul
inflammatori
macrophag
reduc
macrophag
accumul
significantli
increas
consist
find
liver
macrophag
mko
mice
mark
increas
express
antiinflammatori
immunosuppress
gene
name
figur
also
found
strong
induct
tunel
apoptoticnecrot
bodi
mwt
mko
liver
apoptosi
confirm
fa
induc
increas
fasl
stain
mwt
mko
liver
figur
inde
fasl
tnf
releas
hepat
macrophag
decreas
mko
liver
figur
concord
decreas
fa
express
hepatocyt
increas
express
antiapoptot
gene
bclx
l
figur
furthermor
analysi
recruit
dna
bone
marrowderiv
macrophag
bmdm
reveal
bind
upstream
region
fasl
gene
stimul
lp
supplement
figur
fasl
mrna
express
induc
cell
mko
cell
supplement
figur
modul
adapt
immun
respons
previous
attribut
activ
macrophag
furthermor
transcriptom
analysi
lymphocyt
activ
highlight
among
enrich
term
differenti
express
transcript
mko
mwt
mice
inde
follow
acut
ccl
toxic
express
type
type
cytokin
decreas
among
cell
mko
rel
mwt
mice
figur
furthermor
among
cell
observ
increas
express
mko
mice
concord
increas
accumul
regulatori
cell
mko
rel
mwt
mice
figur
rapid
polar
cell
respons
toward
type
immunoregulatori
respons
may
also
contribut
hepatoprotect
phenotyp
mko
mice
collect
find
demonstr
defect
releas
death
effector
fasl
tnf
macrophag
immunosuppress
activ
regulatori
cell
repres
key
mechan
decreas
hepatocyt
apoptosi
myeloid
defici
desensit
hepatocyt
fasinduc
apoptosi
confirm
defect
induct
faslink
apoptosi
mko
mice
appli
model
directli
stimul
fa
death
receptor
administr
antifa
antibodi
clone
four
hour
administr
massiv
hemorrhag
develop
liver
mwt
mice
well
elev
plasma
transaminas
level
expect
hepatocyt
death
mko
mice
show
complet
protect
treatment
liver
structur
maintain
chang
plasma
transaminas
level
figur
tunel
assay
confirm
appear
apoptot
bodi
mwt
mice
mko
mice
figur
liver
damag
seen
mwt
mice
associ
induct
express
cell
respons
treatment
remain
blunt
mko
mice
figur
measur
express
target
proand
antiinflammatori
gene
express
cell
found
decreas
express
mhc
ii
tnf
increas
express
figur
stain
fac
analysi
reveal
decreas
macrophag
accumul
figur
furthermor
similar
respons
ccl
treatment
confirm
gene
express
profil
cell
observ
predomin
macrophag
mko
mice
wherea
inflammatori
macrophag
predomin
among
hepat
macrophag
mwt
mice
figur
addit
altern
macrophag
polar
cell
respons
alter
liver
mko
compar
mwt
mice
observ
follow
acut
ccl
toxic
lack
liver
macrophag
increas
differenti
cell
express
rather
figur
result
demonstr
express
integr
induct
apoptosi
mko
mice
confirm
hepatocyt
desensit
fa
receptormedi
apoptosi
underpin
immunosuppress
polar
macrophag
accumul
regulatori
cell
antiapoptot
respons
knockout
maintain
metabol
stress
confirm
find
metabol
stress
investig
apoptot
phenotyp
inflammatori
respons
liver
mwt
mko
mice
upon
mcdand
bdlinduc
fibrosi
inde
follow
bdl
mcd
treatment
decreas
induct
tunel
apoptosisnecrosi
seen
liver
section
mko
compar
mwt
mice
figur
agreement
previou
observ
ihc
stain
mrna
express
analysi
confirm
fasl
involv
apoptot
liver
phenotyp
mcd
bdl
condit
similar
tunel
stain
fasl
express
found
decreas
mko
compar
mwt
mice
figur
underli
protect
phenotyp
mko
mice
cell
express
immunosuppress
antiinflammatori
gene
increas
wherea
express
proinflammatori
proapoptot
gene
tnf
fasl
decreas
figur
furthermor
mko
mice
differenti
immunosuppress
cell
increas
figur
corrobor
cell
respons
follow
ccl
administr
hepatoprotect
confirm
qrtpcr
analys
fa
bclx
l
inde
fa
express
decreas
mko
rel
mwt
hepatocyt
antiapoptot
gene
express
increas
figur
collect
result
demonstr
toxic
metabol
context
faslink
apoptosi
prevent
mko
mice
immunosuppress
activ
cell
induct
immunoregulatori
cell
respons
observ
sever
model
hepatocellular
stress
thu
strongli
implic
protect
respons
axi
contribut
human
hepat
fibrosi
nash
evalu
relationship
apoptot
role
fa
fasl
human
patholog
next
investig
mrna
express
human
liver
biopsi
control
patient
normal
liver
patient
fatti
liver
nash
lesion
relat
hcv
stratifi
patient
etiolog
express
fasl
fa
significantli
induc
nash
hcv
fatti
liver
control
liver
figur
similar
express
express
fa
fasl
increas
increas
fibrosi
stage
figur
independ
steatosi
supplement
figur
next
investig
correl
fa
fasl
sever
marker
liver
damag
found
signific
posit
correl
plasma
transaminas
bilirubin
contrast
observ
neg
correl
prothrombin
time
known
decreas
liver
damag
supplement
figur
bclextra
larg
bclx
l
mrna
express
primari
hepatocyt
mwt
mko
mice
follow
ccl
treatment
transcriptom
analysi
n
per
group
analys
n
per
group
scale
bar
differ
genotyp
determin
unpair
test
valu
report
mean
sem
p
p
p
transcriptom
filter
base
detect
p
valu
less
differ
control
mwt
chang
adjust
p
valu
less
next
carri
correl
analysi
determin
involv
inflammatori
activ
fasfasl
apoptosi
human
nafld
hcv
found
strong
posit
correl
two
inflammatori
marker
well
strong
posit
correl
fa
fasl
mrna
express
figur
demonstr
regulatori
cascad
control
respons
hepatocellular
stress
develop
liver
fibrosi
figur
demonstr
use
murin
model
hepatocellular
stress
aris
metabol
stress
toxic
stress
direct
cell
death
receptor
stimul
inflammatori
respons
central
induct
hepatocyt
apoptosi
liver
damag
spectrum
nafld
progress
benign
steatosi
patholog
steatohepat
fibrosi
larg
driven
inflamm
furthermor
inflammatori
activ
nash
well
document
part
system
inflamm
character
obes
type
diabet
inflammatori
process
shown
amelior
defici
studi
report
pathway
central
steatohepat
liver
fibrogenesi
mice
human
sever
model
hepatocellular
stress
demonstr
therapeut
knockdown
macrophagederiv
prevent
hepatocyt
apoptosi
protect
induct
immun
system
event
repres
earli
immunosuppress
signal
interfer
chronic
wound
heal
liver
fibrogenesi
absenc
macrophagederiv
liver
antiinflammatori
immunosuppress
macrophag
polar
predomin
allow
releas
antiinflammatori
cytokin
limit
chemokin
product
recruit
monocyt
liver
macrophag
also
character
decreas
death
effector
releas
fasl
tnf
convers
macrophag
undergo
proinflammatori
proapoptot
polar
stress
lead
increas
inflammatori
cytokin
death
effector
releas
induct
hepatocyt
apoptosi
perpetu
scar
fibrogenesi
function
consequ
liver
increas
macrophagederiv
express
favor
cell
differenti
releas
figur
hepatocyt
stress
defici
rapid
secret
macrophag
cell
promot
antiapoptot
signal
bclx
l
hepatocyt
maintain
surviv
prevent
wound
heal
fibrogenesi
previous
describ
figur
underpin
decreas
fibrosi
defici
decreas
hsc
activ
activ
hsc
necessari
event
extracellular
matrix
deposit
fibrogenesi
macrophag
inflammatori
activ
cytokin
releas
hepatocellular
stress
major
mechan
hsc
activ
strongest
known
cytokin
induc
hsc
activ
tnf
wide
known
profibrogen
properti
patholog
effect
liver
diseas
well
document
sever
studi
suggest
therapeut
intervent
signal
howev
also
power
antiinflammatori
immunosuppress
cytokin
thu
attent
increasingli
paid
tempor
consider
cell
typespecif
effect
signal
previous
demonstr
transcript
regul
express
adipos
tissu
macrophag
repress
action
express
reproduc
studi
indic
consist
regul
tissu
although
effect
induc
tissuespecif
observ
emphas
import
tissu
microenviron
dictat
physiolog
patholog
cytokin
role
similar
report
made
regard
metabol
protect
adipos
tissu
yet
deleteri
liver
hepatocyt
apoptosi
featur
common
across
number
liver
etiolog
fibrogenesi
end
product
excess
hepatocellular
stress
hepatocyt
death
perpetu
inflamm
hsc
activ
therapeut
strategi
aim
regul
balanc
antiand
proapoptot
signal
previous
propos
apoptot
process
mediat
death
receptor
stimul
format
complex
cleav
initi
execution
caspas
termin
caspas
cleav
apoptosi
underway
checkpoint
inhibit
progress
termin
caspas
maintain
cell
structur
integr
mean
thu
promot
cell
surviv
three
effector
group
involv
apoptosi
extrins
factor
virus
xenobiot
etc
immun
factor
receptor
ligand
intrins
factor
bile
acid
free
fatti
acid
etc
applic
metabol
stress
mcd
bdl
toxic
stress
ccl
direct
death
receptor
stimul
demonstr
effectorindepend
mechan
promot
hepatocyt
surviv
myeloid
defici
target
instrument
protect
phenotyp
observ
defici
due
power
antiapoptot
antifibrogen
properti
cytokin
studi
demonstr
shamtreat
mice
n
per
group
mice
n
per
group
scale
bar
differ
genotyp
determin
unpair
test
valu
report
mean
sem
p
p
mice
defici
show
aggrav
liver
phenotyp
experiment
fibrosi
rel
wt
mice
express
per
se
suffici
prevent
hepatocyt
death
caspasedepend
apoptosi
strong
induct
famili
member
bclx
l
critic
factor
promot
hepatocyt
surviv
direct
interfer
caspas
cleavag
furthermor
famili
member
subject
numer
lossand
gainoffunct
studi
demonstr
requir
maintain
hepatocyt
surviv
inde
hepatocellular
stress
mko
demonstr
increas
hepatocyt
express
bclx
l
concord
increas
express
leukocyt
essenti
role
kc
induc
hepatocyt
apoptosi
well
document
sato
et
al
demonstr
chlodron
liposom
abolit
kc
prevent
apoptosi
follow
acut
ccl
toxic
also
demonstr
therapeut
neutral
fasl
tnf
antibodi
administr
demonstr
alter
macrophag
inflammatori
polar
suffici
amelior
hepat
respons
ccl
toxic
turn
prevent
experiment
fibrosi
respons
fa
stimul
macrophag
undergo
antiinflammatori
polar
induc
secret
cell
rapid
immunosuppress
differenti
furthermor
upon
fa
stimul
macrophag
defici
render
hepatocyt
complet
resist
apoptosi
resist
previous
demonstr
mice
global
knockout
find
confirm
key
compon
inflammatori
process
drive
hepatocyt
death
mice
import
fasinduc
apoptosi
previous
implic
human
hepat
previou
work
focus
fa
induct
advanc
hepatopatholog
express
earli
marker
hepatocarinogenesi
propos
howev
group
investig
fasfasl
system
earli
direct
marker
fibrogenesi
nash
inde
fa
fasl
express
induc
nash
fibrosi
cohort
similar
express
interest
strong
correl
establish
express
express
fa
fasl
inflammatori
marker
summari
establish
key
role
human
liver
fibrosi
studi
highlight
pathway
instrument
suscept
hepatocyt
apoptosi
figur
protect
effect
inhibit
root
antiinflammatori
macrophag
activ
releas
rapid
expans
immunosuppress
cell
releas
inhibit
fasdepend
apoptosi
hepatocyt
earli
hepatoprotect
prevent
progress
nafld
beyond
benign
steatosi
prevent
inflamm
fibrogenesi
liver
thu
modul
activ
increasingli
promis
approach
experiment
therapeut
fibroinflammatori
liver
diseas
human
tissu
liver
sampl
obtain
patient
surgic
resect
four
main
group
patient
analyz
accord
liver
lesion
normal
liver
control
b
steatosi
without
steatohepat
fatti
liver
c
steatosi
steatohepat
nash
necroinflammatori
lesion
relat
hcv
infect
tabl
patient
without
clinic
histori
cirrhosi
includ
control
sampl
obtain
distanc
benign
hepat
tumor
patient
colorect
carcinoma
inclus
control
base
histolog
serolog
paramet
nafld
hcv
sampl
obtain
distanc
hepatocellular
carcinoma
liver
lesion
score
accord
steatosi
activ
fibrosi
saf
score
fibrosi
stage
nafld
hcv
assess
accord
kleiner
metavir
system
respect
patient
sign
inform
consent
form
local
ethic
committe
approv
studi
tissu
frozen
formalinfix
paraffinembed
rna
extract
patholog
evalu
respect
murin
model
liver
injuri
mice
maintain
hous
convent
condit
biolog
servic
unit
univers
pari
upmc
mice
hous
per
cage
induct
cholestat
liver
injuri
complet
ligat
bile
duct
carri
previous
describ
mice
maintain
day
ligatur
place
initi
progress
fibrosi
sacrif
sampl
anim
diet
anim
week
age
place
highfat
feed
fat
research
diet
week
methioninecholinedefici
feed
week
mcd
diet
research
diet
ad
libitum
access
feed
water
normal
chow
control
anim
receiv
normal
chow
diet
ad
libitum
access
food
water
serolog
blood
sampl
collect
heparin
edtaco
tube
sarstedt
cardiac
punctur
retroorbit
sinu
shortli
mice
sacrif
cervic
disloc
blood
sampl
immedi
centrifug
g
minut
supernat
plasma
aliquot
store
analysi
randox
kit
use
measur
plasma
transaminas
triglycerid
qrtpcr
rna
extract
tissu
cell
use
rneasi
rna
mini
kit
qiagen
complementari
dna
synthes
use
mmlv
superscript
ii
revers
transcriptas
kit
thermofish
reaction
qrtpcr
prepar
sequencespecif
primer
mesa
green
kit
sybr
green
assay
eurogentec
andor
gapdh
use
housekeep
gene
normal
rel
quantif
mrna
express
use
livak
schmittgen
method
primer
list
supplement
tabl
histolog
immunohistochemistri
mous
liver
immedi
collect
tissu
dropfix
formalin
sigmaaldrich
hour
put
autom
carousel
processor
dehydr
clear
paraffin
embed
leica
liver
section
prepar
thick
polyllysin
slide
sigmaaldrich
vwr
section
clear
rehydr
stain
procedur
dehydr
mount
dpx
polymer
mountant
sigmaaldrich
h
e
sigmaaldrich
stain
use
evalu
tissu
morpholog
rp
sigmaaldrich
stain
use
visual
collagen
fiber
follow
manufactur
instruct
epitopespecif
antibodi
use
ihc
detect
fasl
stain
supplement
tabl
ihc
analysi
clear
rehydr
section
quench
h
minut
room
temperatur
wash
twice
minut
tb
volvol
section
block
tb
wtvol
bsa
minut
room
temperatur
section
incub
dilut
primari
antibodi
wash
time
minut
tb
volvol
follow
incub
appropri
hrpconjug
secondari
antibodi
biorad
section
wash
twice
minut
tb
chromogen
detect
carri
dab
chromogen
kit
dako
section
wash
run
water
minut
nuclei
counterstain
hematoxylin
follow
dehydr
mount
imag
acquir
axiovert
microscop
unless
otherwis
differ
patient
group
determin
anova
correl
analys
assess
spearman
test
valu
report
mean
sem
p
p
p
state
ihc
reagent
sourc
sigmaaldrich
quantit
express
immunostain
perform
use
posit
pixel
algorithm
indica
lab
digit
slide
aperio
result
express
percentag
posit
pixel
quantif
method
autom
observerindepend
process
base
wholeslid
scan
applic
publicli
access
algorithm
biolog
replic
repres
one
slide
mount
least
tissu
section
repres
technic
replic
mean
present
result
per
biolog
replic
hepatocyt
mononuclear
cell
separ
liver
wash
pb
transfer
collagenas
digest
solut
dmem
gibco
mgml
collagenas
mgml
mgcl
mgml
cacl
hepe
ul
penicillin
mgml
streptomycin
gl
bsa
sigmaaldrich
liver
rapidli
thoroughli
perfus
collagenas
solut
cut
small
piec
homogen
repeat
passag
syring
lysat
pass
filter
ice
ml
cold
hbss
wtvol
bsa
ad
lysat
centrifug
minut
g
result
pellet
compos
hepatocyt
fraction
supernat
compos
lmnc
hepatocyt
pellet
resuspend
unsuppl
wem
centrifug
minut
g
supernat
remov
pellet
snapfrozen
liquid
nitrogen
lmnc
fraction
centrifug
g
minut
resuspend
rpmi
volvol
fetal
calf
serum
volvol
percol
layer
onto
rpmi
volvol
fetal
calf
serum
volvol
percol
sigmaaldrich
figur
schemat
represent
role
liver
macrophag
respons
hepatocellular
stress
interferon
regulatori
factor
compet
liver
macrophag
undergo
proinflammatori
activ
respons
hepatocellular
stress
proinflammatori
activ
induc
inflammatori
cytokin
death
effector
releas
induc
hepatocyt
caspas
casp
depend
apoptosi
activ
factor
includ
fa
ligand
fasl
tnf
mhc
ii
proinflammatori
activ
induc
type
type
respons
cell
type
cytokin
includ
macrophag
hepatocellular
stress
lead
immunosuppress
reg
polar
secret
express
induc
differenti
cell
cell
contribut
releas
secret
defici
promot
antiapoptot
signal
hepatocyt
mediat
b
cell
lymphoma
famili
member
process
maintain
cell
surviv
stress
percol
gradient
centrifug
minut
g
acceler
deceler
leukocyt
appear
ring
red
blood
cell
gradient
leukocyt
layer
transfer
new
tube
resuspend
red
blood
cell
lysi
buffer
nh
cl
gl
khco
gl
edta
mgl
sampl
agit
minut
room
temperatur
centrifug
minut
g
result
pellet
resuspend
flow
cytometri
stain
buffer
hepe
mm
fetal
calf
serum
volvol
edta
mm
pb
ph
cell
count
redistribut
accord
applic
immunoselect
cell
least
cell
stain
immunoselect
cell
mac
system
miltenyi
biotec
isol
cell
wash
centrifug
g
minut
resuspend
mac
buffer
pb
edta
mm
wtvol
bsa
ph
contain
appropri
dilut
biotinyl
antibodi
miltenyi
biotec
cell
incub
dark
minut
wash
centrifug
g
minut
cell
resuspend
mac
buffer
contain
appropri
dilut
antibiotinconjug
magnet
microbead
miltenyi
biotec
stain
carri
minut
dark
cell
wash
centrifug
resuspend
mac
buffer
cell
suspens
pass
ls
column
miltenyi
biotec
accord
manufactur
instruct
fraction
collect
wash
pb
snapfrozen
liquid
nitrogen
flow
cytometr
analysi
lmnc
cell
cell
taken
surfac
intracellular
stain
respect
cell
centrifug
g
minut
resuspend
flow
cytometri
stain
buffer
contain
fluorochromeconjug
antibodi
stain
dark
minut
cell
fix
andor
permeabil
accord
manufactur
protocol
factor
stain
buffer
set
affymetrix
ebiosci
surfac
stain
cell
wash
centrifug
resuspend
flow
cytometri
stain
buffer
filter
acquisit
nuclear
stain
cytoplasm
epitop
cell
stain
appropri
fluorochromeconjug
antibodi
permeabil
buffer
affymetrix
ebiosci
minut
room
temperatur
dark
cell
wash
resuspend
flow
cytometri
stain
buffer
filter
acquisit
livedead
fixabl
dye
invitrogen
use
discrimin
live
dead
cell
acquisit
made
bd
facsaria
iii
bd
bioscienc
function
assay
cytokin
express
isol
cell
stimul
either
lp
macrophag
stimul
ngml
pma
ngml
ionomycin
lymphocyt
stimul
rpmi
volvol
fetal
calf
serum
mm
lglutamin
mm
hepe
ul
penicillin
mgml
streptomycin
sigmaaldrich
gibco
humidifi
chamber
co
hour
golgistop
protein
transport
inhibitor
ad
immedi
use
bd
pharmingen
cell
block
wash
centrifug
stain
surfac
intracellular
epitop
see
supplement
tabl
marker
reagent
use
rna
sequenc
transcriptom
analysi
librari
prepar
illumina
sequenc
perform
ecol
normal
genom
platform
pari
franc
messeng
polya
rna
purifi
ng
total
rna
use
oligo
dt
librari
prepar
use
strandspecif
rnaseq
librari
tabl
physic
biochem
paramet
associ
control
patient
fatti
liver
nash
hcv
patient
fatti
liver
nash
hcv
prepar
truseq
strand
mrna
kit
illumina
librari
multiplex
run
read
sequenc
perform
nextseq
devic
illumina
mean
million
pass
illumina
qualiti
filter
read
obtain
sampl
analys
perform
use
eoulsan
pipelin
includ
read
filter
map
align
filter
read
quantif
normal
differenti
analysi
map
poli
n
read
tail
trim
read
base
remov
read
qualiti
mean
discard
read
align
genom
use
star
version
ensembl
annot
version
align
read
match
refer
genom
remov
use
java
version
samtool
comput
gene
express
genom
annot
version
ensembl
databas
http
useastensemblorg
use
overlap
region
align
referenc
exon
count
use
htseqcount
sampl
count
normal
use
deseq
statist
treatment
differenti
analys
also
perform
use
deseq
rnaseq
gene
express
data
raw
fastq
file
avail
geo
repositori
http
wwwncbinlmnihgovgeo
access
number
ontolog
cluster
gene
databas
annot
visual
integr
discoveri
david
use
pathway
analys
panther
classif
system
use
visual
result
treeview
cluster
applic
use
statist
data
express
arithmet
mean
sem
unless
otherwis
state
statist
signific
evalu
unpair
student
test
anova
bonferroni
post
hoc
test
pearson
spearman
test
use
determin
correl
p
valu
less
consid
signific
statist
analys
carri
use
graphpad
prism
statist
softwar
studi
approv
procedur
carri
accord
french
guidelin
care
use
experiment
anim
anim
studi
approv
region
veterinari
servic
pari
polic
headquart
agreement
biolog
servic
unit
univers
pari
upmc
patient
gave
written
inform
consent
studi
protocol
approv
ethic
committe
beaujon
hospit
fa
nv
design
research
studi
analyz
data
wrote
manuscript
fa
rb
lo
ih
conduct
vivo
experi
acquir
analyz
data
fl
vp
conduct
human
analysi
wrote
manuscript
cb
sl
conduct
transcriptom
analys
dg
conduct
chipseq
analysi
al
iau
ff
help
experiment
design
wrote
manuscript
